Issue 32, 2008

Vanadium–vitamin B12 bioconjugates as potential therapeutics for treating diabetes

Abstract

The synthesis and blood glucose lowering properties of the first vanadium–vitamin B12 bioconjugates are reported.

Graphical abstract: Vanadium–vitamin B12 bioconjugates as potential therapeutics for treating diabetes

Supplementary files

Article information

Article type
Communication
Submitted
18 Apr 2008
Accepted
01 May 2008
First published
20 Jun 2008

Chem. Commun., 2008, 3783-3785

Vanadium–vitamin B12 bioconjugates as potential therapeutics for treating diabetes

R. Mukherjee, E. G. Donnay, M. A. Radomski, C. Miller, D. A. Redfern, A. Gericke, D. S. Damron and N. E. Brasch, Chem. Commun., 2008, 3783 DOI: 10.1039/B806598E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements